{
    "clinical_study": {
        "@rank": "46745", 
        "acronym": "MSC-SCI", 
        "arm_group": {
            "arm_group_label": "Mesenchymal Stem cells", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The aim of this study is to evaluate the use of autologous expanded mesenchymal stem cells\n      intralesional transplantation as a safe and potentially beneficial treatment for patients\n      with spinal cord injury."
        }, 
        "brief_title": "Autologous Mesenchymal Stem Cells in Spinal Cord Injury (SCI) Patients", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Spinal Cord Injury", 
        "condition_browse": {
            "mesh_term": [
                "Spinal Cord Injuries", 
                "Wounds and Injuries"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  American Spinal Injury Association Impairment (ASIA) Scale A, B and C\n\n          -  Cervical (under C4), thoracic o lumbar spine lesion\n\n          -  Complete or Incomplete SCI\n\n          -  Platelet count over 100.000/ul\n\n        Exclusion Criteria:\n\n          -  Acute SCI (less than 3 months)\n\n          -  Active infectious diseases\n\n          -  Pregnancy\n\n          -  Neurodegenerative diseases\n\n          -  Primary hematologic diseases\n\n          -  Coagulopathies\n\n          -  Hepatic dysfunction\n\n          -  Pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "2 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 25, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01694927", 
            "org_study_id": "LIT-2012-ACF-001"
        }, 
        "intervention": {
            "arm_group_label": "Mesenchymal Stem cells", 
            "description": "Expanded Intralesional Autologous Mesenchymal Stem Cells Transplantation", 
            "intervention_name": "Autologous Mesenchymal Stem Cells", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Mesenchymal stem cell", 
            "Spinal cord injury"
        ], 
        "lastchanged_date": "July 2, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Santiago", 
                    "country": "Chile", 
                    "state": "RM", 
                    "zip": "7591468"
                }, 
                "name": "Cl\u00ednica Las Condes"
            }
        }, 
        "location_countries": {
            "country": "Chile"
        }, 
        "number_of_arms": "1", 
        "official_title": "Autologous Mesenchymal Stem Cells in Spinal Cord Injury (SCI) Patients", 
        "overall_official": [
            {
                "affiliation": "Cl\u00ednica Las Condes, Santiago", 
                "last_name": "Andr\u00e9s Chah\u00edn, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Cl\u00ednica Las Condes, Santiago", 
                "last_name": "Rodrigo M Mardones, MD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Cl\u00ednica Las Condes, Santiago", 
                "last_name": "Catalina Larrain, MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "Chile: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Safety of Autologous Expanded Mesenchymal Stem Cells transplantation in SCI patients", 
            "safety_issue": "Yes", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01694927"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Clinica las Condes, Chile", 
            "investigator_full_name": "Cl\u00ednica Las Condes. LIT INNOVA CORFO", 
            "investigator_title": "Clinical Researcher LIT. Innova CORFO 09IEI6568", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "results_reference": [
            {
                "PMID": "19903102", 
                "citation": "Pal R, Venkataramana NK, Bansal A, Balaraju S, Jan M, Chandra R, Dixit A, Rauthan A, Murgod U, Totey S. Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study. Cytotherapy. 2009;11(7):897-911."
            }, 
            {
                "PMID": "21303266", 
                "citation": "Ra JC, Shin IS, Kim SH, Kang SK, Kang BC, Lee HY, Kim YJ, Jo JY, Yoon EJ, Choi HJ, Kwon E. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev. 2011 Aug;20(8):1297-308. doi: 10.1089/scd.2010.0466. Epub 2011 Mar 17."
            }, 
            {
                "PMID": "16793729", 
                "citation": "Moviglia GA, Fernandez Vi\u00f1a R, Brizuela JA, Saslavsky J, Vrsalovic F, Varela G, Bastos F, Farina P, Etchegaray G, Barbieri M, Martinez G, Picasso F, Schmidt Y, Brizuela P, Gaeta CA, Costanzo H, Moviglia Brandolino MT, Merino S, Pes ME, Veloso MJ, Rugilo C, Tamer I, Shuster GS. Combined protocol of cell therapy for chronic spinal cord injury. Report on the electrical and functional recovery of two patients. Cytotherapy. 2006;8(3):202-9."
            }
        ], 
        "secondary_outcome": [
            {
                "description": "According to motor index score", 
                "measure": "Functional improvement in muscle strength", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "Functional Improvement in sphincters control", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "Functional improvement in spasticity control", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }
        ], 
        "source": "Clinica las Condes, Chile", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cl\u00ednica Las Condes. LIT INNOVA CORFO", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}